menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Ex-CinCor CEO Marc de Garidel lands at Abivax after negotiating $1.8B cash sale

    ENDPTS

    AstraZeneca Acquires CinCor for $1.3B Upfront

    CONTRACT PHARMA

    CinCor Announces Receipt of Minutes with FDA on Planned PIII of Baxdrostat

    GLOBENEWSWIRE

    AstraZeneca eagerness for CinCor revealed in larger first offer

    FIERCE BIOTECH

    How the price of AstraZeneca`s buyout of Cincor fell by $1.4B

    ENDPTS

    AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.

    BUSINESSWIRE

    AstraZeneca to acquire CinCor Pharma in nearly $2 billion deal

    PRESS RELEASE

    CinCor Pharma to be Acquired by AstraZeneca

    GLOBENEWSWIRE

    CinCor`s hypertension drug loses halo after phase 2 fail

    FIERCEBIOTECH

    CinCor Announces Topline Data for Phase 2 HALO Trial Evaluating Baxdrostat

    GLOBENEWSWIRE

    CinCor Pharma to Present at Piper Sandler and Evercore ISI Conferences

    GLOBENEWSWIRE

    CinCor Pharma to Present at Upcoming Jefferies London Healthcare Conference

    PRESS RELEASE

    CinCor Pharma Appoints Michael W. Kalb, Executive VP and CFO

    PRESS RELEASE

    CinCor Pharma Announces Publication in the NEM of Phase 2 BrigHtn Data

    GLOBENEWSWIRE

    CinCor Announces Late-Breaking Presentation of Pha2 BrigHtn Data on Baxdrostat

    GLOBENEWSWIRE

    CinCor Reports Third Quarter Financial Results and Provides Corporate Update

    GLOBENEWSWIRE

    CinCor Pharma Announces Presentation of Phase 1 Clinical Data for Baxdrostat

    GLOBENEWSWIRE

    CinCor Announces Publication of Phase 1 Multiple Ascending Dose Study Data

    GLOBENEWSWIRE

    CinCor Pharma Announces Oral Presentation of Phase 1 Data for Baxdrostat

    CINCOR

    CinCor Pharma Announces Late-Breaking Presentation of Ph2 Data for Baxdrostat

    GLOBENEWSWIRE

    CinCor Pharma, Inc.`s stock is down 5.5%, but insiders still have about US$213k in profit after buying earlier this year

    SIMPLYWALL

    CinCor Pharma to Participate at Upcoming September Investor Conferences

    PRESS RELEASE

    CinCor Announces Presentation of Phase 1 Clinical Data for Baxdrostat

    GLOBENEWSWIRE

    CinCor Pharma Announces Closing of Upsized Public Offering

    GLOBENEWSWIRE

    CinCor raises $225M on back of positive PhII readout

    ENDPOINTS NEWS

    CinCor Pharma Announces Pricing of Upsized Public Offering

    GLOBENEWSWIRE

    CinCor Pharma Announces +ve Topline Data for PII BrigHtn Trial of Baxdrostat

    GLOBENEWSWIRE

    CinCor Reports Second Quarter Financial Results and Provides Corporate Update

    GLOBENEWSWIRE

    CinCor Pharma Announces Proposed Public Offering of Common Stock

    GLOBENEWSWIRE

    CinCor Pharma Announces Last Patient Randomized in Phase 2 HALO Trial

    PRESS RELEASE

    CinCor Pharma Doses First Patient in PII FigHTN-CKD Trial Evaluating CIN-107

    GLOBENEWSWIRE

    CinCor Pharma to Present at the Jefferies Healthcare Conference

    GLOBENEWSWIRE

    CinCor Pharma to Present at Upcoming Investor Conferences

    GLOBENEWSWIRE

    CinCor Reports First Quarter Financial Results and Provides Corporate Update

    GLOBENEWSWIRE

    CinCor Pharma to Participate in Jefferies Biotech on the Bay Summit

    GLOBENEWSWIRE

    CinCor Reports Q4 & Full-Year 2021 Financial Results; Provides Corporate Update

    GLOBENEWSWIRE

    CinCor Pharma to be Added to Russell 2000® and Russell 3000® Indexes

    GLOBENEWSWIRE

    CinCor Pharma to Report Q4 and FY 2021 Financial Results

    GLOBENEWSWIRE

    CinCor Pharma to Present at the 32nd Annual Oppenheimer Healthcare Conference

    GLOBENEWSWIRE

    CinCor Pharma Appoints June Lee to Its Board of Directors

    PRESS RELEASE

    As three biotechs head to Wall Street, a battered sector braces for a pullback

    BIOPHARMADIVE

    CinCor Pharma Announces Pricing of Initial Public Offering

    PRESS RELEASE

    CinCor Pharma Launches Roadshow for Proposed Initial Public Offering of Common Stock

    PRESS RELEASE

    CinCor Doses First Patient in HALO, a Phase 2 Clinical Trial

    GLOBENEWSWIRE

    CinCor Pharma Appoints Terry Coelho as Executive Vice President, CFO

    GLOBENEWSWIRE

    CinCor Pharma makes bags $143M; plans for blood pressure drug

    ENDPTS

    CinCor Pharma Raises $143 Million in Series B Financing

    GLOBENEWSWIRE

    CinCor Pharma Appoints Marc de Garidel as Chief Executive Officer

    GLOBENEWSWIRE

    CinCor Pharma Announces Appointments of three Members to Its Board of Directors

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.